[Elsevier] Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial

unlocked7 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-21 02:07
Reward10points

journalㄩAtherosclerosis

AuthorsㄩJie Lin; Yuan Ji; Gaopin Wang; Xueping Ma; Zhuhua Yao; Xuebin Han; Jie Chen; Jiyan Chen; Wei Huang; Guangma Xu; Daoquan Peng; Peishi Yan; Ping Qiao; Yongming He; Yida Tang; Minghui Wang; Mengqi Zhang; Jianjun Yu; Yu Hao; Changsheng Ma

Published dateㄩ2025-4-

DOIㄩ10.1016/j.atherosclerosis.2025.119120

PDF linkㄩhttps://www.sciencedirect.com/sc ... 021915025000176/pdf

Article linkㄩhttps://doi.org/10.1016/j.atherosclerosis.2025.119120

Article SourceㄩElsevier BV


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    10


Return to the list